SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?


To: Todd D. Wiener who wrote (230)2/10/1998 11:09:00 PM
From: JB Cocallas  Read Replies (1) | Respond to of 420
 
Todd, thanks.
To me it seems that nov is stuck because of the decline in nces for
the same reason you presented.. "For every $3 NCES rises
in price, NOV should increase in price by $1," ]
I agree that the management is good & potential price appreciation
will be realized. Seems most of the funds & big players are in the
market leaders

NOV is the leader in Sales volume amongst its competitors.

What other stock do you follow?